Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Heart Failure Reviews
Published in: Heart Failure Reviews 3/2009

01-09-2009

OSA: the new cardiovascular disease

Part II: overview of cardiovascular diseases associated with obstructive sleep apnea

Authors: Kiran Devulapally, Raymond Pongonis Jr., Rami Khayat

Published in: Heart Failure Reviews | Issue 3/2009

Login to get access

Abstract

Obstructive sleep apnea (OSA), present in 5–15% of adults, is strongly associated with the incidence and poor outcome of hypertension, coronary artery disease, arrhythmia, heart failure, and stroke. Treatment of OSA completely reverses its cardiovascular consequences. In this review, we discuss the clinical evidence for the strong association between OSA and cardiovascular disease and present an argument for approaching OSA as a cardiovascular disease. We particularly focus on the causative relationship between OSA and hypertension, and on the increasingly recognized relationship between OSA and heart failure.
Literature
1.
2.
Center for Disease Control and Prevention. N.C.f.h.S., Health, U.D.o.H.a.H. Services, Editor (2006) National Health Interview Survey: US Census
3.
Marin JM et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053PubMed
4.
5.
6.
Wilcox I et al (1993) Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 16(6):539–544PubMed
7.
8.
9.
10.
Kanagala R et al (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107(20):2589–2594PubMed
11.
12.
13.
Amin RS et al (2002) Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165(10):1395–1399. doi:10.​1164/​rccm.​2105118 PubMed
14.
15.
Kaneko Y et al (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348(13):1233–1241PubMed
16.
McNicholas WT, Bonsigore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156–178. doi:10.​1183/​09031936.​00027406 PubMed
17.
18.
19.
20.
21.
22.
23.
Peker Y et al (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 166(2):159–165. doi:10.​1164/​rccm.​2105124 PubMed
24.
Silverberg DS, Oksenberg A (2001) Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Curr Hypertens Rep 3(3):209–215. doi:10.​1007/​s11906-001-0040-8 PubMed
25.
26.
Lugaresi E et al (1980) Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 3(3–4):221–224PubMed
27.
28.
29.
Suzuki M et al (1996) Blood pressure “dipping” and “non-dipping” in obstructive sleep apnea syndrome patients. Sleep 19(5):382–387PubMed
30.
31.
Sharabi Y et al (2003) Diastolic blood pressure is the first to rise in association with early subclinical obstructive sleep apnea: lessons from periodic examination screening. Am J Hypertens 16(3):236–239. doi:10.​1016/​S0895-7061(02)03250-8 PubMed
32.
33.
Haas DC et al (2005) Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 111(5):614–621. doi:10.​1161/​01.​CIR.​0000154540.​62381.​CF PubMed
34.
35.
Hla KM et al (1994) Sleep apnea and hypertension. A population-based study. Ann Intern Med 120(5):382–388PubMed
36.
37.
Brooks D et al (1997) Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99(1):106–109. doi:10.​1172/​JCI119120 PubMed
38.
Fletcher EC (2001) Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 90(4):1600–1605PubMed
39.
Fletcher EC (2000) Cardiovascular consequences of obstructive sleep apnea: experimental hypoxia and sympathetic activity. Sleep 23(Suppl 4):S127–S131PubMed
40.
Bao G et al (1997) Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83(1):95–101PubMed
41.
Fletcher EC, Bao G (1996) The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep 19(10, Suppl):S210–S212PubMed
42.
Xie A et al (2000) Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 89(4):1333–1339PubMed
43.
44.
Katragadda S et al (1997) Neural mechanism of the pressor response to obstructive and nonobstructive apnea. J Appl Physiol 83(6):2048–2054PubMed
45.
Arabi Y et al (1999) Daytime blood pressure elevation after nocturnal hypoxia. J Appl Physiol 87(2):689–698PubMed
46.
47.
MacMahon S et al (1990) Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335(8692):765–774. doi:10.​1016/​0140-6736(90)90878-9 PubMed
48.
Pepperell JC et al (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359(9302):204–210. doi:10.​1016/​S0140-6736(02)07445-7 PubMed
49.
Campos-Rodriguez F et al (2007) Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 132(6):1847–1852. doi:10.​1378/​chest.​07-1478 PubMed
50.
51.
52.
Adhikary G et al (2001) Gene regulation during intermittent hypoxia: evidence for the involvement of reactive oxygen species. Adv Exp Med Biol 499:297–302PubMed
53.
Prabhakar NR et al (2001) Intermittent hypoxia: cell to system. Am J Physiol Lung Cell Mol Physiol 281(3):L524–L528PubMed
54.
Xie A et al (2001) Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 91(4):1555–1562PubMed
55.
Fletcher EC (1997) Sympathetic activity and blood pressure in the sleep apnea syndrome. Respiration 64(Suppl 1):22–28PubMed
56.
Lavie L, Vishnevsky A, Lavie P (2004) Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27(1):123–128PubMed
57.
Carpagnano GE et al (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124(4):1386–1392. doi:10.​1378/​chest.​124.​4.​1386 PubMed
58.
Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285–1295PubMed
59.
60.
61.
62.
MacCarthy PA, Shah AM (2000) Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 101(15):1854–1860PubMed
63.
64.
Bostrom KB et al (2007) Interaction between the angiotensin-converting enzyme gene insertion/deletion polymorphism and obstructive sleep apnoea as a mechanism for hypertension. J Hypertens 25(4):779–783PubMed
65.
66.
Fletcher EC, Orolinova N, Bader M (2002) Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92(2):627–633PubMed
67.
Fletcher EC, Bao G, Li R (1999) Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34(2):309–314PubMed
68.
69.
Nieminen MS et al (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27(22):2725–2736. doi:10.​1093/​eurheartj/​ehl193 PubMed
70.
71.
Schulz R et al (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162(2 Pt 1):566–570PubMed
72.
73.
74.
Sorajja D et al (2008) Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133(4):927–933PubMed
75.
76.
Alonso-Fernandez A et al (2005) Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest 127(1):15–22. doi:10.​1378/​chest.​127.​1.​15 PubMed
77.
Peled N et al (1999) Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 34(6):1744–1749. doi:10.​1016/​S0735-1097(99)00407-6 PubMed
78.
79.
80.
81.
82.
Shahar E et al (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25PubMed
83.
Peker Y et al (2000) Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162(1):81–86PubMed
84.
Mooe T et al (2001) Sleep-disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 164(10 Pt 1):1910–1913PubMed
85.
86.
87.
Javaheri S (2000) Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 101(4):392–397PubMed
88.
89.
90.
Gilman MP et al (2008) Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 114(3):243–249. doi:10.​1042/​CS20070172 CrossRef
91.
92.
93.
94.
Mehra R, Benjamin EJ, Shahar E et al (2006) Association of nocturnal arrhythmias with sleep-disordered breathing: the sleep heart health study. Am J Respir Crit Care Med 173(8):910–916PubMed
95.
96.
97.
Javaheri S et al (1998) Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21):2154–2159PubMed
98.
Mossey P, Singh GD, Smith ME (1999) More extensive analysis is needed when assessing facial structure in SIDS. BMJ (Clin Res Ed.) 318(7180):396–397
99.
Sin DD et al (1999) Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160(4):1101–1106PubMed
100.
101.
102.
Parker JD et al (1999) Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160(6):1888–1896PubMed
103.
Tkacova R et al (1998) Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 98(21):2269–2275PubMed
104.
Chen L, Shi Q, Scharf SM (2000) Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol 88(3):1051–1060PubMed
105.
Scharf SM, Graver LM, Balaban K (1992) Cardiovascular effects of periodic occlusions of the upper airways in dogs. Am Rev Respir Dis 146(2):321–329PubMed
106.
Chen L, Scharf SM (1998) Systemic and myocardial hemodynamics during periodic obstructive apneas in sedated pigs. J Appl Physiol 84(4):1289–1298PubMed
107.
108.
Usui K et al (2005) Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 45(12):2008–2011. doi:10.​1016/​j.​jacc.​2004.​12.​080 PubMed
109.
110.
Mansfield DR, Naughton MT (2004) Sleep apnea and congestive heart failure. Minerva Med 95(4):257–280PubMed
111.
112.
113.
Sajkov D et al (1994) Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 149(2 Pt 1):416–422PubMed
114.
115.
116.
Weitzenblum E et al (1988) Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138(2):345–349PubMed
117.
118.
Gozal D, Lipton AJ, Jones KL (2002) Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25(1):59–65PubMed
119.
Lavie L et al (2002) Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165(12):1624–1628. doi:10.​1164/​rccm.​20110-040OC PubMed
120.
121.
122.
123.
Alchanatis M et al (2001) Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 68(6):566–572. doi:10.​1159/​000050574 PubMed
124.
Sajkov D et al (2002) Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 165(2):152–158PubMed
125.
126.
Foster GE et al (2007) Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. Am J Respir Crit Care Med 175(7):720–725. doi:10.​1164/​rccm.​200609-1271OC PubMed
127.
Phillips SA et al (2004) Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286(1):H388–H393. doi:10.​1152/​ajpheart.​00683.​2003 PubMed
128.
129.
Suzuki T et al (2004) Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 27(1):129–133PubMed
130.
131.
132.
Turkington PM, Elliott MW (2004) Sleep disordered breathing following stroke. Monaldi Arch Chest Dis 61(3):157–161PubMed
133.
Parra O et al (2000) Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 161(2 Pt 1):375–380PubMed
134.
135.
136.
137.
138.
Kaneko Y et al (2003) Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 26(3):293–297PubMed
139.
140.
Good DC et al (1996) Sleep-disordered breathing and poor functional outcome after stroke. Stroke 27(2):252–259PubMed
Metadata
Title
OSA: the new cardiovascular disease
Part II: overview of cardiovascular diseases associated with obstructive sleep apnea
Authors
Kiran Devulapally
Raymond Pongonis Jr.
Rami Khayat
Publication date
01-09-2009
Publisher
Springer US
Published in
Heart Failure Reviews / Issue 3/2009
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-008-9101-2

Other articles of this Issue 3/2009

Heart Failure Reviews 3/2009 Go to the issue

OriginalPaper

Sleep-associated movement disorders and heart failure

Apnea in Heart Failure

Treatment of sleep disordered breathing in congestive heart failure

OriginalPaper

Insomnia and chronic heart failure

OriginalPaper

Sleep-disordered breathing in patients with decompensated heart failure

OriginalPaper

An integrated approach to managing sleep disordered breathing and cardiovascular disease

Apnea in Heart Failure

Central sleep apnea in patients with congestive heart failure